Illumina faces SEC probe over Grail acquisition
BioPharma
Stay updated with breaking news from Steven Barnard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After a staggering loss in Ohio’s special election this week, anti-abortion activists are grappling with how to forge ahead, POLITICO’s Alice Ollstein reports.
(Bloomberg) -- Shares of Illumina Inc. dropped as much as 7% in late trading after the company cut its sales and profit outlook and said a pair of top executives are departing.Most Read from BloombergFirst American City to Tame Inflation Owes Its Success to Affordable HousingEveryone Wants to Work at UPS After Teamsters DealStock Traders Shun Risk in Run-Up to Key CPI Test: Markets WrapTycoon Who Gave Away $750 Million Sees Profit in Loans to PoorWeWork Tumbles After Raising ‘Substantial Doubt’
By Ben Glickman Illumina said Wednesday that Chief Medical Officer Phil Febbo had departed the company. The San Diego-based gene-sequencing company didn't...
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's...